Table 1.
Group median age | Control n=16 | CRSwNP n=27 | URTI n=8 | ||
---|---|---|---|---|---|
31 | 51 | 32 | |||
Plasma n=15 | Nasal secretions n=4 | Plasma n=24 | Nasal secretions =16 | Plasma & nasal secretions n=8 | |
Median age | 31 | 29 | 47 | 49 | 32 |
Gender F:M | F7:M8 | F1:M3 | F9:M14 | F6:M10 | F4:M4 |
Allergies | 2 | 1 | |||
Asthma | 4 | 2 | |||
Aspirin Sensitivity | 2 | 1 | |||
Previous Surgery | 23 | 2 | 1 | ||
Smoking | |||||
Saline Wash | 4 | 2 | |||
Topical Steroids | 3 | 1 | |||
Systemic Steroids | 1 | ||||
Antibiotics | 1 | ||||
Regular medication | 3 | 2 | 1 | ||
PRN medication | 3 | 2 |
Participant demographics. Of the 16 healthy participants none were on regular medication or had a past medical history involving the ear, nose and throat region of the body. Of participants with CRSwNP all required surgical intervention as a result of persistent disease with poor quality of life following medical intervention. 8 of the CRSwNP participants used topical treatments. One participant had received a course of systemic steroids and antibiotics in the preceding 8 weeks prior to recruitment. Seven participants had a history of asthma and 4 reported aspirin sensitivity.